IRIS
ARDUINI, Arduino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 775
EU - Europa 693
AS - Asia 342
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 771
CN - Cina 179
UA - Ucraina 139
IE - Irlanda 117
SE - Svezia 114
TR - Turchia 103
IT - Italia 96
GB - Regno Unito 76
FR - Francia 75
IN - India 47
DE - Germania 44
FI - Finlandia 24
VN - Vietnam 11
GR - Grecia 3
BE - Belgio 2
CA - Canada 2
CH - Svizzera 1
EU - Europa 1
JP - Giappone 1
MX - Messico 1
NL - Olanda 1
PA - Panama 1
PK - Pakistan 1
PL - Polonia 1
Totale 1.811
Salva come PNG Salva come JPEG
Città #
Chandler 177
Jacksonville 151
Dublin 117
Southend 68
Izmir 67
Princeton 61
Ashburn 48
Nanjing 48
Beijing 45
New York 40
Wilmington 32
Cambridge 26
Chieti 25
Dearborn 22
Nanchang 21
Altamura 16
Ann Arbor 14
Boardman 11
Dong Ket 11
Woodbridge 11
Shenyang 9
Vittuone 9
Washington 9
Jinan 7
Hebei 6
Ningbo 6
Tianjin 6
Jiaxing 5
Kunming 5
Bangalore 4
Falls Church 4
Hefei 4
Norwalk 4
Buccinasco 3
Hangzhou 3
Houston 3
Leawood 3
Pescara 3
Augusta 2
Brussels 2
Changsha 2
Düsseldorf 2
Fino Mornasco 2
Fuzhou 2
Grevenbroich 2
Guangzhou 2
Kocaeli 2
Ottawa 2
Padova 2
Perugia 2
San Mateo 2
Zhengzhou 2
Adliswil 1
Cedar Knolls 1
Clearwater 1
Grafing 1
Haikou 1
Helsinki 1
Kraków 1
Lanzhou 1
Los Angeles 1
Marano di Napoli 1
Mexico City 1
Milan 1
Naples 1
Orange 1
Orlando 1
Ospitaletto 1
Pakistan 1
Panama City 1
Pasadena 1
Porto Sant'elpidio 1
Qingdao 1
Redmond 1
Rotterdam 1
Seattle 1
Simi Valley 1
Taizhou 1
Tappahannock 1
Totale 1.159
Salva come PNG Salva come JPEG
Nome #
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells 111
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 108
null 96
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 94
Defining the potential antidepressant mode of action of acetyl-l-carnitine. 81
L-Carnitine is an osmotic agent suitable for peritoneal dialysis 80
In vitro microbiology studies on a new peritoneal dialysis connector 79
null 79
Vitamin E induction of experimental allergic encephalomyelitis in the Lewis rat. 78
Carnitine in metabolic disease: potential for pharmacological intervention 76
L-carnitine in uremic anemia 74
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 73
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable? 73
Change in plasma amino acid concentrations during breath-hold diving at high altitude. 72
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis 68
Effects of L-carnitine administration on erythrocyte survival in haemodialysis patients 67
Carnitine palmitoyltransferase and acyl-coA binding protein: two more players in the membrane phospholipid fatty acid turnover of human red cells? 66
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine 66
Prevention of peritoneal sclerosis: a new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in vitro and in rabbits) 61
Cellular properties of human erythrocytes preserved in saline-adenine-glucose-mannitol in the presence of L-carnitine 60
Hypercoagulability in uraemia: role of increased surface exposure of phosphatidylserine on erythrocytes 60
L-carnitine may decrease platelet activation response with phosphatidylserine exposure in chronic uraemia 56
null 55
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis 52
La carnitina come agente osmo-metabolico nelle soluzioni di dialisi peritoneale 50
Nuova proposta di sostituire il glucosio con la carnitina nelle soluzioni di dialisi peritoneale 48
Utilità di uno screening urinario in età scolastica 46
How to improve the biocompatibility of peritoneal dialysis solutions (without Jeopardizing the patient’s health) 33
Erythrocyte alterations and increased cardiovascular risk in chronic renal failure 10
Alterazioni eritrocitarie e loro possibile ruolo nelle complicanze cardiovascolari dell’uremia 9
Toward personalized haemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fungerprint 7
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge 5
Totale 1.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201999 0 0 0 0 0 0 0 0 0 1 0 98
2019/2020411 113 25 5 13 28 19 45 31 20 70 35 7
2020/2021234 29 2 32 8 19 37 2 12 38 27 11 17
2021/2022156 11 4 6 37 9 3 7 7 17 6 8 41
2022/2023450 43 63 22 50 49 88 23 21 68 2 14 7
2023/2024211 13 5 17 5 17 116 30 1 1 6 0 0
Totale 1.993